In utero exposure to the anticonvulsant drug valproate increases the risk for poor cognitive outcomes and anatomical malformations in children compared with the 3 other most commonly used anticonvulsant medications, but it appears general practitioners and women of childbearing potential still are not getting the message.
Medscape Medical News
Caroline Cassels
More...